The decrease in caffeic acid might be related to the increase in CD4+CD25+ regulatory T cells in patients with IgG4-RD [22], indicating a potential pathogenesis and treatment target. The gene discussed is CD4; the disease is immunoglobulin G4-related sclerosing disease.